Literature DB >> 8297359

Krabbe disease: isolation and characterization of a full-length cDNA for human galactocerebrosidase.

N Sakai1, K Inui, N Fujii, H Fukushima, J Nishimoto, I Yanagihara, Y Isegawa, A Iwamatsu, S Okada.   

Abstract

Human galactocerebrosidase, the enzyme deficient in Krabbe disease, was purified, through several hydrophobic column steps and gel filtration, 22,650-fold from human lymphocytes. Using information on its N-terminal and internal amino acid sequences, and the polymerase chain reaction method, we cloned a full-length cDNA for the enzyme. The deduced amino acid sequence matched all amino acid sequences determined. The 3780 nucleotide sequence included 2007 nucleotides which encoded a single chain peptide of 669 amino acid residues with a 26 amino acid N-terminal signal peptide and six potential asparagine-linked glycosylation sites. The galactocerebrosidase cDNA detected an about 4 kb mRNA band material in human cultured skin fibroblasts. A nonsense mutation was found at codon 369 (GAA-->TAA) in the coding sequence of cDNA amplified from cultured skin fibroblast mRNA from a patient with typical Krabbe disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8297359     DOI: 10.1006/bbrc.1994.1071

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

Authors:  Je-Seong Won; Avtar K Singh; Inderjit Singh
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

2.  From caveman companion to medical innovator: genomic insights into the origin and evolution of domestic dogs.

Authors:  Heidi G Parker; Samuel F Gilbert
Journal:  Adv Genomics Genet       Date:  2015-06-12

Review 3.  Krabbe Disease in the Arab World.

Authors:  Hatem Zayed
Journal:  J Pediatr Genet       Date:  2015-03

4.  Chaperone therapy for Krabbe disease: potential for late-onset GALC mutations.

Authors:  Mohammad Arif Hossain; Katsumi Higaki; Seiji Saito; Kazuki Ohno; Hitoshi Sakuraba; Eiji Nanba; Yoshiyuki Suzuki; Keiichi Ozono; Norio Sakai
Journal:  J Hum Genet       Date:  2015-06-25       Impact factor: 3.172

5.  The Spectrum of Krabbe Disease in Greece: Biochemical and Molecular Findings.

Authors:  Evangelia Dimitriou; Monica Cozar; Irene Mavridou; Daniel Grinberg; Lluïsa Vilageliu; Helen Michelakakis
Journal:  JIMD Rep       Date:  2015-06-25

6.  Molecular heterogeneity of Krabbe disease.

Authors:  L Fu; K Inui; T Nishigaki; N Tatsumi; H Tsukamoto; C Kokubu; T Muramatsu; S Okada
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

7.  Insights into Krabbe disease from structures of galactocerebrosidase.

Authors:  Janet E Deane; Stephen C Graham; Nee Na Kim; Penelope E Stein; Rosamund McNair; M Begoña Cachón-González; Timothy M Cox; Randy J Read
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

8.  Molecular heterogeneity of late-onset forms of globoid-cell leukodystrophy.

Authors:  R De Gasperi; M A Gama Sosa; E L Sartorato; S Battistini; H MacFarlane; J F Gusella; W Krivit; E H Kolodny
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

9.  Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones.

Authors:  Wing C Lee; Dongcheul Kang; Ena Causevic; Aimee R Herdt; Elizabeth A Eckman; Christopher B Eckman
Journal:  J Neurosci       Date:  2010-04-21       Impact factor: 6.167

10.  Saturation mutagenesis defines novel mouse models of severe spine deformity.

Authors:  Jonathan J Rios; Kristin Denton; Hao Yu; Kandamurugu Manickam; Shannon Garner; Jamie Russell; Sara Ludwig; Jill A Rosenfeld; Pengfei Liu; Jake Munch; Daniel J Sucato; Bruce Beutler; Carol A Wise
Journal:  Dis Model Mech       Date:  2021-06-18       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.